Skip to search formSkip to main contentSkip to account menu

NSC 676914

Known as: NSC-676914, NSC676914 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Synthetic Lethal Screen Identifies NF-κB as a Target for Combination Therapy with Topotecan for patients with Neuroblastoma
BackgroundDespite aggressive multimodal treatments the overall survival of patients with high-risk neuroblastoma remains poor… 
2012
2012
Synthetic Lethal Screen Identifies NF-κB as a Target for Combination Therapy with Topotecan for patients with Neuroblastoma
Despite aggressive multimodal treatments the overall survival of patients with high-risk neuroblastoma remains poor. The aim of… 
2009
2009
A selective small-molecule nuclear factor-κB inhibitor from a high-throughput cell-based assay for “activator protein-1 hits”
NSC 676914 has been identified as a selective nuclear factor-κB (NF-κB) inhibitor that does not inhibit cell proliferation. This… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)